Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 40 46
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Pyronaridine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 3 0
Ebselen Potential treatment - pre-clinical evidence Experimental Antiviral Feb/01/2021 3 2
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
Desethylamodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/08/2020 1 0
Ferroquine Potential treatment - pre-clinical evidence Experimental Antiviral Sep/08/2020 1 0
Quinine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/08/2020 1 0